Montreal—While reversing moderate blockade with sugammadex (Bridion) reduces residual neuromuscular blockade relative to neostigmine, it does so without reducing the incidence of postoperative pulmonary complications, a new study has found.
Nevertheless, the trial found that sugammadex was associated with fewer 30-day hospital readmissions.
Michael Aziz, MD
“We know that residual neuromuscular blockade is associated with postoperative pulmonary complications,” said Michael Aziz,